brimonidine tartrate

FDA Drug Profile — Brimonidine tartrate, Brimonidine Tartrate, brimonidine tartrate, Mirvaso, Brimonidine

brimonidine tartrate is listed in the FDA National Drug Code directory with 19 NDC codes, marketed under brand names including Brimonidine tartrate, Brimonidine Tartrate, brimonidine tartrate. Available dosage forms: solution/ drops, powder, gel.

Drug details

Generic Name
brimonidine tartrate
Brand Names
Brimonidine tartrate, Brimonidine Tartrate, brimonidine tartrate, Mirvaso, Brimonidine, LUMIFY PRESERVATIVE FREE EYE DROPS, ALPHAGAN P
Application Number
NDA021262
Sponsor
Pacific Pharma, Inc.
NDC Codes
19
Dosage Forms
SOLUTION/ DROPS, POWDER, GEL
Routes
OPHTHALMIC, TOPICAL
Active Ingredients
BRIMONIDINE TARTRATE

Indications and Usage

1 INDICATIONS AND USAGE Brimonidine tartrate ophthalmic solution 0.1% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Brimonidine tartrate ophthalmic solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.